EDGAR Filing Documents for 0001193125-23-237298

Form 8-K - Current report:

SEC Accession No. 0001193125-23-237298

Filing Date

2023-09-19

Accepted

2023-09-19 08:06:01

Documents

Period of Report

2023-09-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d511611d8k.htm iXBRL	8-K	33086
2	EX-4.1	d511611dex41.htm	EX-4.1	95125
3	EX-4.2	d511611dex42.htm	EX-4.2	95252
4	EX-4.3	d511611dex43.htm	EX-4.3	22802
5	EX-10.1	d511611dex101.htm	EX-10.1	78074
6	EX-99.1	d511611dex991.htm	EX-99.1	9034
10	GRAPHIC	g511611g0919061845831.jpg	GRAPHIC	4157
	Complete submission text file	0001193125-23-237298.txt		550628

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	bior-20230918.xsd	EX-101.SCH	2868
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	bior-20230918_lab.xml	EX-101.LAB	18737
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	bior-20230918_pre.xml	EX-101.PRE	11719
12	EXTRACTED XBRL INSTANCE DOCUMENT	d511611d8k_htm.xml	XML	3479

Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122

Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639

BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)